Estimate Recalculated May 9, 2026 10:52AM EST
MPM Oncology Impact Management GP LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Werewolf Therapeutics, Inc., iTeos Therapeutics, Inc., Spring Bank Pharmaceuticals, Inc., Harpoon Therapeutics, Inc., TCR2 THERAPEUTICS INC., SUNESIS PHARMACEUTICALS INC, Oncorus, Inc., and Cullinan Management, Inc..
MPM Oncology Impact Management GP LLC's CIK is 0001721035
No data available
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!